HEADER IMMUNE SYSTEM 29-APR-24 9BL3 TITLE KIR3DL1*114 IN COMPLEX WITH HLA-B*57:03 PRESENTING THE AW10 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA-B ALPHA CHAIN (B*5703GB); COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MHC CLASS I ANTIGEN, HUMAN LEUKOCYTE ANTIGEN B*57:03; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: UNP RESIDUES 21-119; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: CATENIN ALPHA-1 PEPTIDE; COMPND 13 CHAIN: C; COMPND 14 FRAGMENT: RESIDUES 850-859 (UNIPROT NUMBERING); COMPND 15 SYNONYM: ALPHA E-CATENIN,CADHERIN-ASSOCIATED PROTEIN,RENAL CARCINOMA COMPND 16 ANTIGEN NY-REN-13; COMPND 17 ENGINEERED: YES; COMPND 18 MOL_ID: 4; COMPND 19 MOLECULE: KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR 3DL1; COMPND 20 CHAIN: G; COMPND 21 FRAGMENT: RESIDUES 1-299; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: B2M, CDABP0092, HDCMA22P; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 14 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_COMMON: HUMAN; SOURCE 19 ORGANISM_TAXID: 9606; SOURCE 20 MOL_ID: 4; SOURCE 21 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 22 ORGANISM_COMMON: HUMAN; SOURCE 23 ORGANISM_TAXID: 9606; SOURCE 24 GENE: KIR3DL1; SOURCE 25 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 26 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 27 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS IMMUNOGLOBULIN FOLD, NATURAL KILLER CELL RECEPTOR, KIR, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR C.FAORO,J.ROSSJOHN REVDAT 1 13-NOV-24 9BL3 0 JRNL AUTH L.LOH,P.M.SAUNDERS,C.FAORO,N.FONT-PORTERIAS,N.NEMAT-GORGANI, JRNL AUTH 2 G.F.HARRISON,S.SADEEQ,L.HENSEN,S.C.WONG,J.WIDJAJA, JRNL AUTH 3 E.B.CLEMENS,S.ZHU,K.M.KICHULA,S.TAO,F.ZHU,G.MONTERO-MARTIN, JRNL AUTH 4 M.FERNANDEZ-VINA,L.A.GUETHLEIN,J.P.VIVIAN,J.DAVIES, JRNL AUTH 5 A.J.MENTZER,S.J.OPPENHEIMER,W.POMAT,A.G.IOANNIDIS, JRNL AUTH 6 C.BARBERENA-JONAS,A.MORENO-ESTRADA,A.MILLER,P.PARHAM, JRNL AUTH 7 J.ROSSJOHN,S.Y.C.TONG,K.KEDZIERSKA,A.G.BROOKS,P.J.NORMAN JRNL TITL AN ARCHAIC HLA CLASS I RECEPTOR ALLELE DIVERSIFIES NATURAL JRNL TITL 2 KILLER CELL-DRIVEN IMMUNITY IN FIRST NATIONS PEOPLES OF JRNL TITL 3 OCEANIA. JRNL REF CELL 2024 JRNL REFN ISSN 1097-4172 JRNL PMID 39476840 JRNL DOI 10.1016/J.CELL.2024.10.005 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.10 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 48369 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 2351 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.1000 - 5.1400 0.98 2731 136 0.1627 0.1954 REMARK 3 2 5.1400 - 4.0800 0.98 2684 147 0.1368 0.1828 REMARK 3 3 4.0800 - 3.5700 0.98 2765 129 0.1594 0.1967 REMARK 3 4 3.5700 - 3.2400 0.98 2674 148 0.1859 0.1951 REMARK 3 5 3.2400 - 3.0100 0.98 2737 145 0.2127 0.2426 REMARK 3 6 3.0100 - 2.8300 0.98 2721 136 0.2292 0.2614 REMARK 3 7 2.8300 - 2.6900 0.97 2727 136 0.2337 0.2968 REMARK 3 8 2.6900 - 2.5700 0.98 2689 131 0.2355 0.3198 REMARK 3 9 2.5700 - 2.4700 0.98 2706 131 0.2401 0.2792 REMARK 3 10 2.4700 - 2.3900 0.98 2739 145 0.2338 0.2658 REMARK 3 11 2.3900 - 2.3100 0.97 2715 130 0.2328 0.2491 REMARK 3 12 2.3100 - 2.2500 0.98 2684 138 0.2333 0.2670 REMARK 3 13 2.2500 - 2.1900 0.97 2708 131 0.2397 0.2959 REMARK 3 14 2.1900 - 2.1300 0.97 2667 164 0.2442 0.2771 REMARK 3 15 2.1300 - 2.0900 0.97 2702 137 0.2602 0.2982 REMARK 3 16 2.0900 - 2.0400 0.97 2681 143 0.2697 0.3106 REMARK 3 17 2.0400 - 2.0000 0.97 2688 124 0.3003 0.3282 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.257 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.902 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 5592 REMARK 3 ANGLE : 0.896 7625 REMARK 3 CHIRALITY : 0.055 807 REMARK 3 PLANARITY : 0.008 997 REMARK 3 DIHEDRAL : 14.129 2032 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9BL3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAY-24. REMARK 100 THE DEPOSITION ID IS D_1000283636. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-APR-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.953659 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48382 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 48.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.46300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG 3350, 2% TACSIMATE PH 5.0, 0.1 REMARK 280 M TRI-SODIUM CITRATE PH 5.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS G 1 REMARK 465 MET G 2 REMARK 465 GLY G 3 REMARK 465 GLY G 4 REMARK 465 GLN G 5 REMARK 465 ALA G 240 REMARK 465 GLY G 296 REMARK 465 ASN G 297 REMARK 465 PRO G 298 REMARK 465 SER G 299 REMARK 465 HIS G 300 REMARK 465 HIS G 301 REMARK 465 HIS G 302 REMARK 465 HIS G 303 REMARK 465 HIS G 304 REMARK 465 HIS G 305 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 79 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 83 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 89 CG CD OE1 OE2 REMARK 470 LYS A 186 CG CD CE NZ REMARK 470 GLU A 222 CG CD OE1 OE2 REMARK 470 ILE B 1 CG1 CG2 CD1 REMARK 470 GLU B 47 CG CD OE1 OE2 REMARK 470 LYS B 75 CG CD CE NZ REMARK 470 SER B 88 OG REMARK 470 MET B 99 CG SD CE REMARK 470 ARG G 33 CG CD NE CZ NH1 NH2 REMARK 470 ASP G 43 CG OD1 OD2 REMARK 470 ARG G 44 CG CD NE CZ NH1 NH2 REMARK 470 GLN G 56 CG CD OE1 NE2 REMARK 470 LYS G 212 CG CD CE NZ REMARK 470 ARG G 226 CG CD NE CZ NH1 NH2 REMARK 470 HIS G 241 CG ND1 CD2 CE1 NE2 REMARK 470 HIS G 266 CG ND1 CD2 CE1 NE2 REMARK 470 VAL G 294 CG1 CG2 REMARK 470 THR G 295 OG1 CG2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 151 CZ REMARK 480 SER A 251 CA CB OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -119.51 49.56 REMARK 500 SER A 42 70.05 54.80 REMARK 500 ASN A 114 113.42 -161.48 REMARK 500 SER A 195 -161.89 -168.04 REMARK 500 GLN A 224 49.06 -90.54 REMARK 500 TRP B 60 -0.52 80.10 REMARK 500 HIS G 46 -0.42 69.41 REMARK 500 SER G 186 170.99 -59.40 REMARK 500 ALA G 264 38.97 -164.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 9BL2 RELATED DB: PDB DBREF 9BL3 A 1 276 UNP I3ZN84 I3ZN84_HUMAN 25 300 DBREF 9BL3 B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 9BL3 C 1 10 UNP P35221 CTNA1_HUMAN 850 859 DBREF1 9BL3 G 1 299 UNP A0A5J6VN80_HUMAN DBREF2 9BL3 G A0A5J6VN80 22 320 SEQADV 9BL3 MET B 0 UNP P61769 INITIATING METHIONINE SEQADV 9BL3 HIS G 300 UNP A0A5J6VN8 EXPRESSION TAG SEQADV 9BL3 HIS G 301 UNP A0A5J6VN8 EXPRESSION TAG SEQADV 9BL3 HIS G 302 UNP A0A5J6VN8 EXPRESSION TAG SEQADV 9BL3 HIS G 303 UNP A0A5J6VN8 EXPRESSION TAG SEQADV 9BL3 HIS G 304 UNP A0A5J6VN8 EXPRESSION TAG SEQADV 9BL3 HIS G 305 UNP A0A5J6VN8 EXPRESSION TAG SEQRES 1 A 276 GLY SER HIS SER MET ARG TYR PHE TYR THR ALA MET SER SEQRES 2 A 276 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 276 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 276 ALA ALA SER PRO ARG MET ALA PRO ARG ALA PRO TRP ILE SEQRES 5 A 276 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 A 276 ASN MET LYS ALA SER ALA GLN THR TYR ARG GLU ASN LEU SEQRES 7 A 276 ARG ILE ALA LEU ARG TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 276 SER HIS ILE ILE GLN VAL MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 276 PRO ASP GLY ARG LEU LEU ARG GLY HIS ASN GLN TYR ALA SEQRES 10 A 276 TYR ASP GLY LYS ASP TYR ILE ALA LEU ASN GLU ASP LEU SEQRES 11 A 276 SER SER TRP THR ALA ALA ASP THR ALA ALA GLN ILE THR SEQRES 12 A 276 GLN ARG LYS TRP GLU ALA ALA ARG VAL ALA GLU GLN LEU SEQRES 13 A 276 ARG ALA TYR LEU GLU GLY LEU CYS VAL GLU TRP LEU ARG SEQRES 14 A 276 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG ALA SEQRES 15 A 276 ASP PRO PRO LYS THR HIS VAL THR HIS HIS PRO ILE SER SEQRES 16 A 276 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU GLY PHE SEQRES 17 A 276 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 276 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 276 PRO ALA GLY ASP ARG THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 276 VAL VAL PRO SER GLY GLU GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 276 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 276 TRP GLU PRO SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 10 ALA SER LEU ASN LEU PRO ALA VAL SER TRP SEQRES 1 G 305 HIS MET GLY GLY GLN ASP LYS PRO PHE LEU SER ALA TRP SEQRES 2 G 305 PRO SER ALA VAL VAL PRO ARG GLY GLY HIS VAL THR LEU SEQRES 3 G 305 ARG CYS HIS TYR ARG HIS ARG PHE ASN ASN PHE MET LEU SEQRES 4 G 305 TYR LYS GLU ASP ARG ILE HIS VAL PRO ILE PHE HIS GLY SEQRES 5 G 305 ARG LEU PHE GLN GLU SER PHE ASN MET SER PRO VAL THR SEQRES 6 G 305 THR ALA HIS ALA GLY ASN TYR THR CYS ARG GLY SER HIS SEQRES 7 G 305 PRO HIS SER PRO THR GLY TRP SER ALA ALA SER ASN PRO SEQRES 8 G 305 VAL VAL ILE MET VAL THR GLY ASN HIS ARG LYS PRO SER SEQRES 9 G 305 LEU LEU ALA HIS PRO GLY PRO LEU VAL LYS SER GLY GLU SEQRES 10 G 305 ARG VAL ILE LEU GLN CYS TRP SER ASP ILE MET PHE GLU SEQRES 11 G 305 HIS PHE PHE LEU HIS LYS GLU GLY ILE SER LYS ASP PRO SEQRES 12 G 305 SER ARG LEU VAL GLY GLN ILE HIS ASP GLY VAL SER LYS SEQRES 13 G 305 ALA ASN PHE SER ILE GLY PRO MET MET PHE ALA LEU ALA SEQRES 14 G 305 GLY THR TYR ARG CYS TYR GLY SER VAL THR HIS THR PRO SEQRES 15 G 305 TYR GLN LEU SER ALA PRO SER ASP PRO LEU ASP ILE VAL SEQRES 16 G 305 VAL THR GLY PRO TYR GLU LYS PRO SER LEU SER ALA GLN SEQRES 17 G 305 PRO GLY PRO LYS VAL GLN ALA GLY GLU SER VAL THR LEU SEQRES 18 G 305 SER CYS SER SER ARG SER SER TYR ASP MET TYR HIS LEU SEQRES 19 G 305 SER ARG GLU GLY GLY ALA HIS GLU ARG ARG LEU PRO ALA SEQRES 20 G 305 VAL ARG LYS VAL ASN ARG THR PHE GLN ALA ASP PHE PRO SEQRES 21 G 305 LEU GLY PRO ALA THR HIS GLY GLY THR TYR ARG CYS PHE SEQRES 22 G 305 GLY SER PHE ARG HIS SER PRO TYR GLU TRP SER ASP PRO SEQRES 23 G 305 SER ASP PRO LEU LEU VAL SER VAL THR GLY ASN PRO SER SEQRES 24 G 305 HIS HIS HIS HIS HIS HIS HET NAG G 401 14 HET NAG G 402 14 HET NAG G 403 14 HET NAG G 404 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 5 NAG 4(C8 H15 N O6) FORMUL 9 HOH *385(H2 O) HELIX 1 AA1 ALA A 49 GLU A 53 5 5 HELIX 2 AA2 GLY A 56 ASN A 86 1 31 HELIX 3 AA3 ASP A 137 ALA A 150 1 14 HELIX 4 AA4 ARG A 151 GLY A 162 1 12 HELIX 5 AA5 GLY A 162 GLY A 175 1 14 HELIX 6 AA6 GLY A 175 GLN A 180 1 6 HELIX 7 AA7 GLU A 253 GLN A 255 5 3 HELIX 8 AA8 PRO G 48 ARG G 53 1 6 HELIX 9 AA9 THR G 65 ALA G 69 5 5 HELIX 10 AB1 MET G 165 ALA G 169 5 5 SHEET 1 AA1 8 ALA A 46 PRO A 47 0 SHEET 2 AA1 8 THR A 31 ASP A 37 -1 N ARG A 35 O ALA A 46 SHEET 3 AA1 8 ARG A 21 VAL A 28 -1 N GLY A 26 O PHE A 33 SHEET 4 AA1 8 HIS A 3 MET A 12 -1 N THR A 10 O ILE A 23 SHEET 5 AA1 8 ILE A 94 VAL A 103 -1 O VAL A 103 N HIS A 3 SHEET 6 AA1 8 LEU A 109 TYR A 118 -1 O LEU A 110 N ASP A 102 SHEET 7 AA1 8 LYS A 121 LEU A 126 -1 O LEU A 126 N ASN A 114 SHEET 8 AA1 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AA2 4 LYS A 186 PRO A 193 0 SHEET 2 AA2 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AA2 4 PHE A 241 PRO A 250 -1 O ALA A 245 N CYS A 203 SHEET 4 AA2 4 GLU A 229 LEU A 230 -1 N GLU A 229 O ALA A 246 SHEET 1 AA3 4 LYS A 186 PRO A 193 0 SHEET 2 AA3 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AA3 4 PHE A 241 PRO A 250 -1 O ALA A 245 N CYS A 203 SHEET 4 AA3 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 AA4 4 GLU A 222 ASP A 223 0 SHEET 2 AA4 4 THR A 214 ARG A 219 -1 N ARG A 219 O GLU A 222 SHEET 3 AA4 4 TYR A 257 GLN A 262 -1 O HIS A 260 N THR A 216 SHEET 4 AA4 4 LEU A 270 LEU A 272 -1 O LEU A 272 N CYS A 259 SHEET 1 AA5 4 LYS B 6 SER B 11 0 SHEET 2 AA5 4 ASN B 21 PHE B 30 -1 O SER B 28 N LYS B 6 SHEET 3 AA5 4 PHE B 62 PHE B 70 -1 O THR B 68 N LEU B 23 SHEET 4 AA5 4 GLU B 50 HIS B 51 -1 N GLU B 50 O TYR B 67 SHEET 1 AA6 4 LYS B 6 SER B 11 0 SHEET 2 AA6 4 ASN B 21 PHE B 30 -1 O SER B 28 N LYS B 6 SHEET 3 AA6 4 PHE B 62 PHE B 70 -1 O THR B 68 N LEU B 23 SHEET 4 AA6 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 AA7 4 GLU B 44 ARG B 45 0 SHEET 2 AA7 4 GLU B 36 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 AA7 4 TYR B 78 ASN B 83 -1 O ARG B 81 N ASP B 38 SHEET 4 AA7 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 AA8 3 PHE G 9 TRP G 13 0 SHEET 2 AA8 3 VAL G 24 HIS G 29 -1 O ARG G 27 N SER G 11 SHEET 3 AA8 3 PHE G 59 MET G 61 -1 O MET G 61 N VAL G 24 SHEET 1 AA9 4 VAL G 17 PRO G 19 0 SHEET 2 AA9 4 VAL G 92 THR G 97 1 O MET G 95 N VAL G 18 SHEET 3 AA9 4 GLY G 70 GLY G 76 -1 N TYR G 72 O VAL G 92 SHEET 4 AA9 4 PHE G 37 LYS G 41 -1 N TYR G 40 O THR G 73 SHEET 1 AB1 4 SER G 104 HIS G 108 0 SHEET 2 AB1 4 VAL G 119 SER G 125 -1 O GLN G 122 N LEU G 106 SHEET 3 AB1 4 VAL G 154 ILE G 161 -1 O PHE G 159 N LEU G 121 SHEET 4 AB1 4 GLN G 149 HIS G 151 -1 N GLN G 149 O LYS G 156 SHEET 1 AB2 5 LEU G 112 LYS G 114 0 SHEET 2 AB2 5 LEU G 192 THR G 197 1 O VAL G 195 N VAL G 113 SHEET 3 AB2 5 GLY G 170 SER G 177 -1 N GLY G 170 O ILE G 194 SHEET 4 AB2 5 HIS G 131 LYS G 136 -1 N HIS G 135 O ARG G 173 SHEET 5 AB2 5 SER G 144 VAL G 147 -1 O LEU G 146 N PHE G 132 SHEET 1 AB3 3 LEU G 112 LYS G 114 0 SHEET 2 AB3 3 LEU G 192 THR G 197 1 O VAL G 195 N VAL G 113 SHEET 3 AB3 3 GLU G 282 TRP G 283 1 O TRP G 283 N VAL G 196 SHEET 1 AB4 4 SER G 204 GLN G 208 0 SHEET 2 AB4 4 THR G 220 SER G 225 -1 O SER G 222 N SER G 206 SHEET 3 AB4 4 PHE G 255 PRO G 260 -1 O PHE G 255 N SER G 225 SHEET 4 AB4 4 VAL G 248 ARG G 249 -1 N VAL G 248 O GLN G 256 SHEET 1 AB5 5 LYS G 212 VAL G 213 0 SHEET 2 AB5 5 LEU G 290 VAL G 294 1 O SER G 293 N VAL G 213 SHEET 3 AB5 5 GLY G 267 SER G 275 -1 N TYR G 270 O LEU G 290 SHEET 4 AB5 5 MET G 231 ARG G 236 -1 N HIS G 233 O PHE G 273 SHEET 5 AB5 5 GLU G 242 PRO G 246 -1 O LEU G 245 N TYR G 232 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.09 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.02 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.01 SSBOND 4 CYS G 28 CYS G 74 1555 1555 2.06 SSBOND 5 CYS G 123 CYS G 174 1555 1555 2.06 SSBOND 6 CYS G 223 CYS G 272 1555 1555 2.04 LINK ND2 ASN G 60 C1 NAG G 403 1555 1555 1.45 LINK ND2 ASN G 71 C1 NAG G 404 1555 1555 1.44 LINK ND2 ASN G 158 C1 NAG G 402 1555 1555 1.45 LINK ND2 ASN G 252 C1 NAG G 401 1555 1555 1.44 CISPEP 1 TYR A 209 PRO A 210 0 -0.45 CISPEP 2 HIS B 31 PRO B 32 0 4.23 CISPEP 3 TRP G 13 PRO G 14 0 1.50 CISPEP 4 SER G 62 PRO G 63 0 -8.40 CISPEP 5 HIS G 108 PRO G 109 0 3.04 CISPEP 6 GLY G 162 PRO G 163 0 1.24 CISPEP 7 GLY G 198 PRO G 199 0 9.80 CISPEP 8 GLN G 208 PRO G 209 0 -0.01 CISPEP 9 GLY G 262 PRO G 263 0 -4.60 CRYST1 51.769 60.784 65.042 95.56 98.16 109.02 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019317 0.006657 0.003835 0.00000 SCALE2 0.000000 0.017401 0.002695 0.00000 SCALE3 0.000000 0.000000 0.015717 0.00000